Moderna, Inc.NASDAQ: MRNA

Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026

· Issued by Moderna, Inc. via ACCESS Newswire

Summary by 6ix AI

Moderna, Inc., a company developing mRNA (messenger RNA) medicines, will host a live conference call and webcast at 8:00 a.m. ET on Friday, November 6, 2026 to report its third quarter 2026 financial results and give a corporate update.

Key details

  • The live webcast will be available under "Events and Presentations" in the Investors section of the Moderna website.
  • An archived webcast will be posted on Moderna's website approximately two hours after the call and will remain available for one year.

6ix AI wrote this summary from the release below and checked it against the release.

CAMBRIDGE, MA / ACCESS Newswire / October 13, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, November 6, 2026 to report its third quarter 2026 financial results, and provide a corporate update.

A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.

The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]

SOURCE: Moderna, Inc.

View original source (ACCESS Newswire)Moderna, Inc. on 6ix

Story so far

Earlier from Moderna

Later from Moderna

All Moderna news releases